Section Arrow
Quote
TRIB.NASDAQ
- Trinity Biotech plc
(Financial Status)
Quotes are at least 15-min delayed:2026/06/21 07:34 EDT
Regular Hours
Last
 0.58
+0.0001 (+0.02%)
Day High 
0.64 
Prev. Close
0.5799 
1-M High
0.75 
Volume 
191.49K 
Bid
0.57
Ask
0.64
Day Low
0.5731 
Open
0.59 
1-M Low
0.5596 
Market Cap 
11.74M 
Currency 美元 
P/E -- 
%Yield 37.93 
10-SMA 0.65 
20-SMA 0.66 
50-SMA 0.65 
52-W High 17.2 
52-W Low 0.5012 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.00/-0.49
Enterprise Value
38.91M
Balance Sheet
Book Value Per Share
-3.55
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
56.83M
Operating Revenue Per Share
3.58
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BFLYButterfly Network8.9+3.19+55.87%-- 
ABTAbbott Laboratories88.41-0.09-0.10%24.76PE
TNONTenon Medical Inc0.35-0.2521-41.87%-- 
BSXBoston Scientific Corp45.29+0.34+0.76%18.95PE
MDTMedtronic plc79.34+1.2+1.54%22.16PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.